Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young.

Vaxillaire M, Froguel P, Bonnefond A.

Curr Diab Rep. 2019 Aug 5;19(9):79. doi: 10.1007/s11892-019-1202-x. Review.

PMID:
31385057
2.

The unique clinical spectrum of maturity onset diabetes of the young type 3.

Lebenthal Y, Fisch Shvalb N, Gozlan Y, Tenenbaum A, Tenenbaum-Rakover Y, Vaillant E, Froguel P, Vaxillaire M, Gat-Yablonski G.

Diabetes Res Clin Pract. 2018 Jan;135:18-22. doi: 10.1016/j.diabres.2017.10.024. Epub 2017 Oct 28.

PMID:
29107759
3.

A novel NEUROG3 mutation in neonatal diabetes associated with a neuro-intestinal syndrome.

Hancili S, Bonnefond A, Philippe J, Vaillant E, De Graeve F, Sand O, Busiah K, Robert JJ, Polak M, Froguel P, Güven A, Vaxillaire M.

Pediatr Diabetes. 2018 May;19(3):381-387. doi: 10.1111/pedi.12576. Epub 2017 Sep 22.

PMID:
28940958
4.

Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling.

Yengo L, Arredouani A, Marre M, Roussel R, Vaxillaire M, Falchi M, Haoudi A, Tichet J; D.E.S.I.R Study Group, Balkau B, Bonnefond A, Froguel P.

Mol Metab. 2016 Aug 23;5(10):918-925. doi: 10.1016/j.molmet.2016.08.011. eCollection 2016 Oct.

5.
6.

Monogenic diabetes: Implementation of translational genomic research towards precision medicine.

Vaxillaire M, Froguel P.

J Diabetes. 2016 Nov;8(6):782-795. doi: 10.1111/1753-0407.12446. Epub 2016 Sep 7. Review.

7.

What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity?

Philippe J, Derhourhi M, Durand E, Vaillant E, Dechaume A, Rabearivelo I, Dhennin V, Vaxillaire M, De Graeve F, Sand O, Froguel P, Bonnefond A.

PLoS One. 2015 Nov 23;10(11):e0143373. doi: 10.1371/journal.pone.0143373. eCollection 2015.

8.

RFX6 regulates insulin secretion by modulating Ca2+ homeostasis in human β cells.

Chandra V, Albagli-Curiel O, Hastoy B, Piccand J, Randriamampita C, Vaillant E, Cavé H, Busiah K, Froguel P, Vaxillaire M, Rorsman P, Polak M, Scharfmann R.

Cell Rep. 2014 Dec 24;9(6):2206-18. doi: 10.1016/j.celrep.2014.11.010. Epub 2014 Dec 11.

9.

Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study.

Vaxillaire M, Yengo L, Lobbens S, Rocheleau G, Eury E, Lantieri O, Marre M, Balkau B, Bonnefond A, Froguel P.

Diabetologia. 2014 Aug;57(8):1601-10. doi: 10.1007/s00125-014-3277-x. Epub 2014 Jun 4.

PMID:
24893864
10.

Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].

Busiah K, Drunat S, Vaivre-Douret L, Bonnefond A, Simon A, Flechtner I, Gérard B, Pouvreau N, Elie C, Nimri R, De Vries L, Tubiana-Rufi N, Metz C, Bertrand AM, Nivot-Adamiak S, de Kerdanet M, Stuckens C, Jennane F, Souchon PF, Le Tallec C, Désirée C, Pereira S, Dechaume A, Robert JJ, Phillip M, Scharfmann R, Czernichow P, Froguel P, Vaxillaire M, Polak M, Cavé H; French NDM study group.

Lancet Diabetes Endocrinol. 2013 Nov;1(3):199-207. doi: 10.1016/S2213-8587(13)70059-7. Epub 2013 Sep 6. Erratum in: Lancet Diabetes Endocrinol. 2013 Nov;1(3):e14.

PMID:
24622368
11.

Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing.

Bonnefond A, Philippe J, Durand E, Muller J, Saeed S, Arslan M, Martínez R, De Graeve F, Dhennin V, Rabearivelo I, Polak M, Cavé H, Castaño L, Vaxillaire M, Mandel JL, Sand O, Froguel P.

Diabetes Care. 2014 Feb;37(2):460-7. doi: 10.2337/dc13-0698. Epub 2013 Sep 16.

PMID:
24041679
12.

Transcription factor gene MNX1 is a novel cause of permanent neonatal diabetes in a consanguineous family.

Bonnefond A, Vaillant E, Philippe J, Skrobek B, Lobbens S, Yengo L, Huyvaert M, Cavé H, Busiah K, Scharfmann R, Polak M, Abdul-Rasoul M, Froguel P, Vaxillaire M.

Diabetes Metab. 2013 May;39(3):276-80. doi: 10.1016/j.diabet.2013.02.007. Epub 2013 Apr 4.

PMID:
23562494
13.

Familial early-onset diabetes is not a typical MODY in several Tunisian patients.

Amara A, Chadli-Chaieb M, Ghezaiel H, Philippe J, Brahem R, Dechaume A, Saad A, Chaieb L, Froguel P, Gribaa M, Vaxillaire M.

Tunis Med. 2012 Dec;90(12):882-7. Erratum in: Tunis Med. 2013 Oct;91(10):604. Froguele, Philippe [corrected to Froguel, Philippe].

14.

Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.

Bonnefond A, Yengo L, Philippe J, Dechaume A, Ezzidi I, Vaillant E, Gjesing AP, Andersson EA, Czernichow S, Hercberg S, Hadjadj S, Charpentier G, Lantieri O, Balkau B, Marre M, Pedersen O, Hansen T, Froguel P, Vaxillaire M.

Diabetologia. 2013 Mar;56(3):492-6. doi: 10.1007/s00125-012-2794-8. Epub 2012 Dec 6.

PMID:
23224494
15.

GATA6 inactivating mutations are associated with heart defects and, inconsistently, with pancreatic agenesis and diabetes.

Bonnefond A, Sand O, Guerin B, Durand E, De Graeve F, Huyvaert M, Rachdi L, Kerr-Conte J, Pattou F, Vaxillaire M, Polak M, Scharfmann R, Czernichow P, Froguel P.

Diabetologia. 2012 Oct;55(10):2845-2847. doi: 10.1007/s00125-012-2645-7. Epub 2012 Jul 18. No abstract available.

PMID:
22806356
16.

Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene.

Bonnefond A, Philippe J, Durand E, Dechaume A, Huyvaert M, Montagne L, Marre M, Balkau B, Fajardy I, Vambergue A, Vatin V, Delplanque J, Le Guilcher D, De Graeve F, Lecoeur C, Sand O, Vaxillaire M, Froguel P.

PLoS One. 2012;7(6):e37423. doi: 10.1371/journal.pone.0037423. Epub 2012 Jun 11.

17.

Glucose-dependent regulation of NR2F2 promoter and influence of SNP-rs3743462 on whole body insulin sensitivity.

Boutant M, Ramos OH, Lecoeur C, Vaillant E, Philippe J, Zhang P, Perilhou A, Valcarcel B, Sebert S, Jarvelin MR, Balkau B, Scott D, Froguel P, Vaxillaire M, Vasseur-Cognet M.

PLoS One. 2012;7(5):e35810. doi: 10.1371/journal.pone.0035810. Epub 2012 May 14.

18.

The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis.

Vaxillaire M, Bonnefond A, Froguel P.

Best Pract Res Clin Endocrinol Metab. 2012 Apr;26(2):171-87. doi: 10.1016/j.beem.2011.12.001. Review.

PMID:
22498247
19.

European genetic variants associated with type 2 diabetes in North African Arabs.

Cauchi S, Ezzidi I, El Achhab Y, Mtiraoui N, Chaieb L, Salah D, Nejjari C, Labrune Y, Yengo L, Beury D, Vaxillaire M, Mahjoub T, Chikri M, Froguel P.

Diabetes Metab. 2012 Oct;38(4):316-23. doi: 10.1016/j.diabet.2012.02.003. Epub 2012 Mar 29.

PMID:
22463974
20.

Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.

Bonnefond A, Clément N, Fawcett K, Yengo L, Vaillant E, Guillaume JL, Dechaume A, Payne F, Roussel R, Czernichow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantieri O, Langenberg C, Bouatia-Naji N; Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC), Charpentier G, Vaxillaire M, Rocheleau G, Wareham NJ, Sladek R, McCarthy MI, Dina C, Barroso I, Jockers R, Froguel P.

Nat Genet. 2012 Jan 29;44(3):297-301. doi: 10.1038/ng.1053.

21.

Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.

Riveline JP, Rousseau E, Reznik Y, Fetita S, Philippe J, Dechaume A, Hartemann A, Polak M, Petit C, Charpentier G, Gautier JF, Froguel P, Vaxillaire M.

Diabetes Care. 2012 Feb;35(2):248-51. doi: 10.2337/dc11-1469. Epub 2011 Dec 30.

22.

Human mutation within Per-Arnt-Sim (PAS) domain-containing protein kinase (PASK) causes basal insulin hypersecretion.

Semplici F, Vaxillaire M, Fogarty S, Semache M, Bonnefond A, Fontés G, Philippe J, Meur G, Diraison F, Sessions RB, Rutter J, Poitout V, Froguel P, Rutter GA.

J Biol Chem. 2011 Dec 23;286(51):44005-14. doi: 10.1074/jbc.M111.254995. Epub 2011 Nov 7.

23.

Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8).

Babenko AP, Vaxillaire M.

FEBS Lett. 2011 Nov 16;585(22):3555-9. doi: 10.1016/j.febslet.2011.10.020. Epub 2011 Oct 19.

24.

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.

Thanabalasingham G, Shah N, Vaxillaire M, Hansen T, Tuomi T, Gašperíková D, Szopa M, Tjora E, James TJ, Kokko P, Loiseleur F, Andersson E, Gaget S, Isomaa B, Nowak N, Raeder H, Stanik J, Njolstad PR, Malecki MT, Klimes I, Groop L, Pedersen O, Froguel P, McCarthy MI, Gloyn AL, Owen KR.

Diabetologia. 2011 Nov;54(11):2801-10. doi: 10.1007/s00125-011-2261-y. Epub 2011 Aug 4.

PMID:
21814873
25.

Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus.

Bonnefond A, Lomberk G, Buttar N, Busiah K, Vaillant E, Lobbens S, Yengo L, Dechaume A, Mignot B, Simon A, Scharfmann R, Neve B, Tanyolaç S, Hodoglugil U, Pattou F, Cavé H, Iovanna J, Stein R, Polak M, Vaxillaire M, Froguel P, Urrutia R.

J Biol Chem. 2011 Aug 12;286(32):28414-24. doi: 10.1074/jbc.M110.215822. Epub 2011 May 18.

26.

Familial mild hyperglycemia associated with a novel ABCC8-V84I mutation within three generations.

Gonsorcikova L, Vaxillaire M, Pruhova S, Dechaume A, Dusatkova P, Cinek O, Pedersen O, Froguel P, Hansen T, Lebl J.

Pediatr Diabetes. 2011 May;12(3 Pt 2):266-9. doi: 10.1111/j.1399-5448.2010.00719.x. Epub 2011 Jan 9.

PMID:
21214702
27.

Conserved intramolecular disulfide bond is critical to trafficking and fate of ATP-binding cassette (ABC) transporters ABCB6 and sulfonylurea receptor 1 (SUR1)/ABCC8.

Fukuda Y, Aguilar-Bryan L, Vaxillaire M, Dechaume A, Wang Y, Dean M, Moitra K, Bryan J, Schuetz JD.

J Biol Chem. 2011 Mar 11;286(10):8481-92. doi: 10.1074/jbc.M110.174516. Epub 2011 Jan 3.

28.

Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome.

Bonnefond A, Durand E, Sand O, De Graeve F, Gallina S, Busiah K, Lobbens S, Simon A, Bellanné-Chantelot C, Létourneau L, Scharfmann R, Delplanque J, Sladek R, Polak M, Vaxillaire M, Froguel P.

PLoS One. 2010 Oct 26;5(10):e13630. doi: 10.1371/journal.pone.0013630.

29.

The emerging genetics of type 2 diabetes.

Bonnefond A, Froguel P, Vaxillaire M.

Trends Mol Med. 2010 Sep;16(9):407-16. doi: 10.1016/j.molmed.2010.06.004. Epub 2010 Aug 20. Review.

PMID:
20728409
30.

Monogenic forms of diabetes mellitus: an update.

Vaxillaire M, Froguel P.

Endocrinol Nutr. 2009 Dec;56 Suppl 4:26-9. Review. No abstract available.

PMID:
20629227
31.

Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels.

Bouatia-Naji N, Bonnefond A, Baerenwald DA, Marchand M, Bugliani M, Marchetti P, Pattou F, Printz RL, Flemming BP, Umunakwe OC, Conley NL, Vaxillaire M, Lantieri O, Balkau B, Marre M, Lévy-Marchal C, Elliott P, Jarvelin MR, Meyre D, Dina C, Oeser JK, Froguel P, O'Brien RM.

Diabetes. 2010 Oct;59(10):2662-71. doi: 10.2337/db10-0389. Epub 2010 Jul 9.

32.

Monogenic forms of diabetes mellitus: an update.

Vaxillaire M, Froguel P.

Endocrinol Nutr. 2009 Dec;56S4:26-29. No abstract available.

PMID:
20542223
33.

Study of TNFalpha -308G/A and IL6 -174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population.

Bouhaha R, Baroudi T, Ennafaa H, Vaillant E, Abid H, Sassi R, Vatin V, Froguel P, Gaaied AB, Meyre D, Vaxillaire M.

Clin Biochem. 2010 Apr;43(6):549-52. doi: 10.1016/j.clinbiochem.2010.01.008. Epub 2010 Feb 2.

PMID:
20132806
34.

Pancreatic hypoplasia presenting with neonatal diabetes mellitus in association with congenital heart defect and developmental delay.

Balasubramanian M, Shield JP, Acerini CL, Walker J, Ellard S, Marchand M, Polak M, Vaxillaire M, Crolla JA, Bunyan DJ, Mackay DJ, Temple IK.

Am J Med Genet A. 2010 Feb;152A(2):340-6. doi: 10.1002/ajmg.a.33194.

PMID:
20082465
35.

Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention.

Meur G, Simon A, Harun N, Virally M, Dechaume A, Bonnefond A, Fetita S, Tarasov AI, Guillausseau PJ, Boesgaard TW, Pedersen O, Hansen T, Polak M, Gautier JF, Froguel P, Rutter GA, Vaxillaire M.

Diabetes. 2010 Mar;59(3):653-61. doi: 10.2337/db09-1091. Epub 2009 Dec 10.

36.

Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proença C, Bacot F, Balkau B, Belisle A, Borch-Johnsen K, Charpentier G, Dina C, Durand E, Elliott P, Hadjadj S, Järvelin MR, Laitinen J, Lauritzen T, Marre M, Mazur A, Meyre D, Montpetit A, Pisinger C, Posner B, Poulsen P, Pouta A, Prentki M, Ribel-Madsen R, Ruokonen A, Sandbaek A, Serre D, Tichet J, Vaxillaire M, Wojtaszewski JF, Vaag A, Hansen T, Polychronakos C, Pedersen O, Froguel P, Sladek R.

Nat Genet. 2009 Oct;41(10):1110-5. doi: 10.1038/ng.443. Epub 2009 Sep 6. Erratum in: Nat Genet. 2009 Oct;41(10):1156.

PMID:
19734900
37.

Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Bonnefond A, Vaxillaire M, Labrune Y, Lecoeur C, Chèvre JC, Bouatia-Naji N, Cauchi S, Balkau B, Marre M, Tichet J, Riveline JP, Hadjadj S, Gallois Y, Czernichow S, Hercberg S, Kaakinen M, Wiesner S, Charpentier G, Lévy-Marchal C, Elliott P, Jarvelin MR, Horber F, Dina C, Pedersen O, Sladek R, Meyre D, Froguel P.

Diabetes. 2009 Nov;58(11):2687-97. doi: 10.2337/db09-0652. Epub 2009 Aug 3.

38.

Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes.

Vaxillaire M, D P, Bonnefond A, Froguel P.

Pediatr Endocrinol Rev. 2009 Mar;6(3):405-17. Review.

PMID:
19396026
39.

Linkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1q.

Prokopenko I, Zeggini E, Hanson RL, Mitchell BD, Rayner NW, Akan P, Baier L, Das SK, Elliott KS, Fu M, Frayling TM, Groves CJ, Gwilliam R, Scott LJ, Voight BF, Hattersley AT, Hu C, Morris AD, Ng M, Palmer CN, Tello-Ruiz M, Vaxillaire M, Wang CR, Stein L, Chan J, Jia W, Froguel P, Elbein SC, Deloukas P, Bogardus C, Shuldiner AR, McCarthy MI; International Type 2 Diabetes 1q Consortium.

Diabetes. 2009 Jul;58(7):1704-9. doi: 10.2337/db09-0081. Epub 2009 Apr 23.

40.

The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects.

Choquet H, Cavalcanti-Proença C, Lecoeur C, Dina C, Cauchi S, Vaxillaire M, Hadjadj S, Horber F, Potoczna N, Charpentier G, Ruiz J, Hercberg S, Maimaitiming S, Roussel R, Boenhnke M, Jackson AU, Patsch W, Krempler F, Voight BF, Altshuler D, Groop L, Thorleifsson G, Steinthorsdottir V, Stefansson K, Balkau B, Froguel P, Meyre D.

Hum Mol Genet. 2009 Jul 1;18(13):2495-501. doi: 10.1093/hmg/ddp169. Epub 2009 Apr 18.

PMID:
19377085
41.

Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study.

Ezzidi I, Mtiraoui N, Cauchi S, Vaillant E, Dechaume A, Chaieb M, Kacem M, Almawi WY, Froguel P, Mahjoub T, Vaxillaire M.

BMC Med Genet. 2009 Apr 15;10:33. doi: 10.1186/1471-2350-10-33.

42.

Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.

Hartemann-Heurtier A, Simon A, Bellanné-Chantelot C, Reynaud R, Cavé H, Polak M, Vaxillaire M, Grimaldi A.

Diabetes Metab. 2009 Jun;35(3):233-5. doi: 10.1016/j.diabet.2009.01.003. Epub 2009 Apr 1.

PMID:
19342262
43.

G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.

Sparsø T, Bonnefond A, Andersson E, Bouatia-Naji N, Holmkvist J, Wegner L, Grarup N, Gjesing AP, Banasik K, Cavalcanti-Proença C, Marchand M, Vaxillaire M, Charpentier G, Jarvelin MR, Tichet J, Balkau B, Marre M, Lévy-Marchal C, Faerch K, Borch-Johnsen K, Jørgensen T, Madsbad S, Poulsen P, Vaag A, Dina C, Hansen T, Pedersen O, Froguel P.

Diabetes. 2009 Jun;58(6):1450-6. doi: 10.2337/db08-1660. Epub 2009 Mar 26.

44.

Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study.

Dahlman I, Nilsson M, Gu HF, Lecoeur C, Efendic S, Ostenson CG, Brismar K, Gustafsson JA, Froguel P, Vaxillaire M, Dahlman-Wright K, Steffensen KR.

BMC Med Genet. 2009 Mar 17;10:27. doi: 10.1186/1471-2350-10-27.

45.

TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia.

Bouhaha R, Choquet H, Meyre D, Abid Kamoun H, Ennafaa H, Baroudi T, Sassi R, Vaxillaire M, Elgaaied A, Froguel P, Cauchi S.

Pathol Biol (Paris). 2010 Dec;58(6):426-9. doi: 10.1016/j.patbio.2009.01.003. Epub 2009 Mar 14.

PMID:
19286335
46.

Mutations in G6PC2 do not contribute to monogenic forms of early infancy diabetes and beta cell dysfunction.

Bonnefond A, Bouatia-Naji N, Simon A, Saint-Martin C, Dechaume A, de Lonlay P, Polak M, Bellanné-Chantelot C, Froguel P, Vaxillaire M.

Diabetologia. 2009 May;52(5):982-5. doi: 10.1007/s00125-009-1299-6. Epub 2009 Feb 24. No abstract available.

PMID:
19238352
47.

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, Sparsø T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chèvre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jørgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S, Balkau B, Lévy-Marchal C, Pattou F, Meyre D, Blakemore AI, Jarvelin MR, Walley AJ, Hansen T, Dina C, Pedersen O, Froguel P.

Nat Genet. 2009 Jan;41(1):89-94. doi: 10.1038/ng.277. Epub 2008 Dec 7.

PMID:
19060909
48.

Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose.

Dahlman I, Vaxillaire M, Nilsson M, Lecoeur C, Gu HF, Cavalcanti-Proença C, Efendic S, Ostenson CG, Brismar K, Charpentier G, Gustafsson JA, Froguel P, Dahlman-Wright K, Steffensen KR.

Pharmacogenet Genomics. 2008 Nov;18(11):967-75. doi: 10.1097/FPC.0b013e32831101ef.

PMID:
18854778
49.

Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Balkau B, Lange C, Fezeu L, Tichet J, de Lauzon-Guillain B, Czernichow S, Fumeron F, Froguel P, Vaxillaire M, Cauchi S, Ducimetière P, Eschwège E.

Diabetes Care. 2008 Oct;31(10):2056-61. doi: 10.2337/dc08-0368. Epub 2008 Aug 8.

50.

Effect of ENPP1/PC-1-K121Q and PPARgamma-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population.

Bouhaha R, Meyre D, Kamoun HA, Ennafaa H, Vaillant E, Sassi R, Baroudi T, Vatin V, Froguel P, Elgaaied A, Vaxillaire M.

Diabetes Res Clin Pract. 2008 Sep;81(3):278-83. doi: 10.1016/j.diabres.2008.06.004. Epub 2008 Jul 25.

PMID:
18657335

Supplemental Content

Loading ...
Support Center